AMPH1 is first identified as a human autoantigen in neurological paraneoplastic autoimmune diseases with breast cancer,6 and then AMPH1 antibodies are detected in the serum of patients with small‐cell lung cancer.7 Here, AMPH is linked to breast carcinoma.